Topic: New Jersey
Merck: Integration of new Schering-Plough unit is track, new drugs are approaching approvalDrugmaker Merck & Co. says its integration of Schering Plough Corp. is off to a good start, with sales and other operations already combined in the top 20 companies where ...
Pfizer on track for speedy pruning, alignment of research programs post Wyeth acquisitionMegamergers in the pharmaceutical industry usually take many months to sort out, but the two research directors at newly combined Pfizer Inc. and Wyeth say they're off to a running ...
Drugmaker Merck & Co. is considering selling some of its veterinary medicine assets or the animal health business of Schering-Plough Corp., as it prepares to acquire its New Jersey neighbor. Merck executives said as much when they announced the $41.1 billion deal ...
States rated in bioscience achievementA breakdown of states on middle school and high school bioscience performance, as measured by a report released Monday by Battelle, the Biotechnology Industry Organization and the Biotechnology Institute: _Leaders of the Pack: Connecticut, Massachusetts, Minnesota, New Hampshire, ...
The state known as the nation's medicine chest is bleeding from sweeping job cuts to its high-paying pharmaceutical industry. "When the pharmaceutical industry catches a cold it sneezes first in New Jersey," said Bob Franks, president of the HealthCare Institute of New ...
Family sues drug company to get access to muscular dystrophy drugA Minnesota family is trying to force a New Jersey drug company to give their son an experimental drug for a fatal form of muscular dystrophy, saying he'll die without it. The ...
Drug makers beset by growing generic competition, few new blockbusters, drug safety concerns and pressure from insurers and government health programs to discount prices are cutting tens of thousands of jobs. Nearly all of the largest pharmaceutical companies by U.S. sales are ...
